Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. by Jizhao Li (5856650)

Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Patient demographics. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

Analysis of Significantly Different ARGs and Resistance Mechanisms. by Xu Jia (187142)

Functional characterization of skinned myocardium prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

SD and mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database. by Yu Zhang (12946)

Subjects:

a.) Mean FB ratios by sample. b) Mean FB ratios by racial group. by Zoë Dinkel (21402766)

Maternal mean arterial pressure. by Pedro Henrique Salles Brito (10441343)

Subjects:

Characteristics of the participants (mean ± SD): Age and biomarkers. by Chul-young Bae (14709766)

Characteristics of the participants (mean ± SD): Lifestyle (numeric). by Chul-young Bae (14709766)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. by Hongyu Li (1332669)

Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

Related inflammation evaluation indexes before and after operation (mean±standard deviation). by Na Wang (193263)

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)